Smith & Nephew (SNNUF) Gains from Investment Securities (2009 - 2024)
Smith & Nephew (SNNUF) reported Gains from Investment Securities of -$71.0 million for Q4 2024, down 12.7% on a YoY basis from -$81.3 million in Q1 2024, and down 12.7% quarter-over-quarter from -$63.0 million in Q4 2023.
Smith & Nephew (SNNUF) Gains from Investment Securities (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Gains from Investment Securities for 16 years, with the latest figure at -$71.0 million in Q4 2024.
- For the quarter ending Q4 2024, Gains from Investment Securities fell 12.7% year-over-year to -$71.0 million; the trailing twelve-month figure through Dec 2024 stood at -$179.0 million (down 28.78% YoY), and the FY2025 full-year result was $23.0 million, up 4.55% from the prior year.
- Gains from Investment Securities for Q4 2024 stood at -$71.0 million, down from -$63.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $13.0 million in Q4 2022, with the low at -$71.0 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged -$42.0 million across 5 years, with a median of -$58.0 million in 2021.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities surged 122.41% — and 2023, when it sank 584.62%.
- Smith & Nephew's Gains from Investment Securities stood at -$31.0 million in 2020, then sank by 87.1% to -$58.0 million in 2021, then surged by 122.41% to $13.0 million in 2022, then slumped by 584.62% to -$63.0 million in 2023, then slipped by 12.7% to -$71.0 million in 2024.
- The last three Gains from Investment Securities figures came in at -$71.0 million (Q4 2024), -$63.0 million (Q4 2023), and $13.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Smith & Nephew | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -71.00 Mn |
| Dec 31, 2024 | -71.00 Mn |
| Dec 31, 2023 | -63.00 Mn |
| Dec 31, 2023 | -63.00 Mn |
| Dec 31, 2022 | 13.00 Mn |
| Dec 31, 2022 | 13.00 Mn |
| Dec 31, 2021 | -58.00 Mn |
| Dec 31, 2021 | -58.00 Mn |
| Dec 31, 2020 | -31.00 Mn |
| Dec 31, 2020 | -31.00 Mn |
| Dec 31, 2019 | -150.00 Mn |
| Dec 31, 2019 | -150.00 Mn |
| Dec 31, 2018 | -125.00 Mn |
| Dec 31, 2018 | -125.00 Mn |
| Dec 31, 2017 | -135.00 Mn |
| Dec 31, 2017 | -135.00 Mn |
| Dec 31, 2016 | -141.00 Mn |
| Dec 31, 2016 | -141.00 Mn |
| Dec 31, 2015 | -137.00 Mn |
| Dec 31, 2015 | -137.00 Mn |